and CD8 on the Cell Surface Absence of an Interaction between pMHCI on CTL Activation and Occurs in the Binding: This Is Paralleled by Their Effects Peptide-MHC Class I (pMHCI) Multimer Anti-CD8 Antibodies Can Inhibit or Enhance

A. Price, Vincenzo Cerundolo and Andy K. SewellLissina, Emma Jones, Fareed Mirza, P. Rod Dunbar, David Linda Wooldridge, Sarah L. Hutchinson, Ed M. Choi, Annahttp://www.jimmunol.org/content/171/12/6650J Immunol€2003; 171:6650-6660; ;Referenceshttp://www.jimmunol.org/content/171/12/6650.full#ref-list-1This article cites 55 articles, 28 of which you can access for free at: Subscriptionshttp://jimmunol.org/subscriptionsInformation about subscribing to The Journal of Immunology is online at: Permissionshttp://www.aai.org/ji/copyright.htmlSubmit copyright permission requests at: Email Alertshttp://jimmunol.org/cgi/alerts/etocReceive free email-alerts when new articles cite this article. Sign up at:

[1]  P. Baumgaertner,et al.  The β1 and β3 Integrins Promote T Cell Receptor-mediated Cytotoxic T Lymphocyte Activation* , 2003, Journal of Biological Chemistry.

[2]  Andrew K. Sewell,et al.  The CD8 T Cell Coreceptor Exhibits Disproportionate Biological Activity at Extremely Low Binding Affinities* , 2003, Journal of Biological Chemistry.

[3]  D. Legler,et al.  Soluble Major Histocompatibility Complex-Peptide Octamers with Impaired CD8 Binding Selectively Induce Fas-dependent Apoptosis* 210 , 2003, The Journal of Biological Chemistry.

[4]  David M Kranz,et al.  Quantitative analysis of the contribution of TCR/pepMHC affinity and CD8 to T cell activation. , 2003, Immunity.

[5]  O. Michielin,et al.  CD3δ Establishes a Functional Link between the T Cell Receptor and CD8* , 2003, The Journal of Biological Chemistry.

[6]  H. Ploegh,et al.  Mouse MHC class I tetramers that are unable to bind to CD8 reveal the need for CD8 engagement in order to activate naive CD8 T cells , 2002, European journal of immunology.

[7]  V. Cerundolo,et al.  The use of chimeric A2K(b) tetramers to monitor HLA A2 immune responses in HLA A2 transgenic mice. , 2002, Journal of immunological methods.

[8]  E. Palmer,et al.  A Role for the α-Chain Connecting Peptide Motif in Mediating TCR-CD8 Cooperation , 2002, The Journal of Immunology.

[9]  Andrew K. Sewell,et al.  Novel CD8+ T Cell Antagonists Based on β2-Microglobulin* , 2002, The Journal of Biological Chemistry.

[10]  P. Rod Dunbar,et al.  Competition Between CTL Narrows the Immune Response Induced by Prime-Boost Vaccination Protocols1 , 2002, The Journal of Immunology.

[11]  Ian A Wilson,et al.  The specificity of TCR/pMHC interaction. , 2002, Current opinion in immunology.

[12]  R. König.  Interactions between MHC molecules and co-receptors of the TCR. , 2002, Current opinion in immunology.

[13]  F. Wurm,et al.  CD8beta endows CD8 with efficient coreceptor function by coupling T cell receptor/CD3 to raft-associated CD8/p56(lck) complexes. , 2001 .

[14]  A. Sewell,et al.  An inter-species difference in the CD8 coreceptor , 2001 .

[15]  Ellis L. Reinherz,et al.  Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[16]  Andrew K. Sewell,et al.  The Human CD8 Coreceptor Effects Cytotoxic T Cell Activation and Antigen Sensitivity Primarily by Mediating Complete Phosphorylation of the T Cell Receptor ζ Chain* , 2001, The Journal of Biological Chemistry.

[17]  Y. Reiter,et al.  Critical Role for CD8 in Binding of MHC Tetramers to TCR: CD8 Antibodies Block Specific Binding of Human Tumor- Specific MHC-Peptide Tetramers to TCR1 , 2001, The Journal of Immunology.

[18]  T. Braciale,et al.  Cutting Edge: Lipid Raft Integrity Affects the Efficiency of MHC Class I Tetramer Binding and Cell Surface TCR Arrangement on CD8+ T Cells1 , 2001, The Journal of Immunology.

[19]  Ellis L. Reinherz,et al.  T Cell Receptor Binding to a pMHCII Ligand Is Kinetically Distinct from and Independent of CD4* , 2001, The Journal of Biological Chemistry.

[20]  E. Palmer,et al.  Essential Role of CD8 Palmitoylation in CD8 Coreceptor Function1 , 2000, The Journal of Immunology.

[21]  C. Tournay,et al.  Efficient detection and immunomagnetic sorting of specific T cells using multimers of MHC class I and peptide with reduced CD8 binding , 2000, Nature Medicine.

[22]  David I. Stuart,et al.  Classical and Nonclassical Class I Major Histocompatibility Complex Molecules Exhibit Subtle Conformational Differences That Affect Binding to CD8αα* , 2000, The Journal of Biological Chemistry.

[23]  S. Jameson,et al.  Critical Role for Cd8 in T Cell Receptor Binding and Activation by Peptide/Major Histocompatibility Complex Multimers , 2000, The Journal of experimental medicine.

[24]  D. Price,et al.  Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. , 1999, Journal of immunology.

[25]  G. Ogg,et al.  Cutting edge: rapid cloning of tumor-specific CTL suitable for adoptive immunotherapy of melanoma. , 1999, Journal of immunology.

[26]  A. Lanzavecchia,et al.  Developmental Regulation of Lck Targeting to the CD8 Coreceptor Controls Signaling in Naive and Memory T Cells , 1999, The Journal of experimental medicine.

[27]  A. Hamad,et al.  Potent T Cell Activation with Dimeric Peptide–Major Histocompatibility Complex Class II Ligand: The Role of CD4 Coreceptor , 1998, The Journal of experimental medicine.

[28]  J. Altman,et al.  Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected]. , 1998, Immunity.

[29]  P. Marrack,et al.  Detection of antigen-specific T cells with multivalent soluble class II MHC covalent peptide complexes. , 1998, Immunity.

[30]  G. Ogg,et al.  Direct isolation, phenotyping and cloning of low-frequency antigen-specific cytotoxic T lymphocytes from peripheral blood , 1998, Current Biology.

[31]  R. Zamoyska,et al.  Co‐capping studies reveal CD8/TCR interactions after capping CD8β polypeptides and intracellular associations of CD8 with p56lck , 1998, European journal of immunology.

[32]  Y. Chien,et al.  CD4 augments the response of a T cell to agonist but not to antagonist ligands. , 1997, Immunity.

[33]  R. Phillips,et al.  Antagonism of cytotoxic T lymphocyte‐mediated lysis by natural HIV‐1 altered peptide ligands requires simultaneous presentation of agonist and antagonist peptides , 1997, European journal of immunology.

[34]  D. Stuart,et al.  Crystal structure of the complex between human CD8αα and HLA-A2 , 1997, Nature.

[35]  R. Zamoyska,et al.  Is CD8 dependence a true reflection of TCR affinity for antigen? , 1993, International immunology.

[36]  D. Kranz,et al.  Role of CD8 in staphylococcal enterotoxin B-mediated lysis by cytotoxic T lymphocytes. , 1993, Journal of immunology.

[37]  K. Eichmann,et al.  Biochemical evidence of the physical association of the majority of CD3 δ chains with the accessory/co‐receptor molecules CD4 and CD8 on nonactivated T lymphocytes , 1992, European journal of immunology.

[38]  J. Guardiola,et al.  Identification of a CD4 binding site on the β2 domain of HLA-DR molecules , 1992, Nature.

[39]  R. Germain,et al.  MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8 , 1992, Nature.

[40]  P. Parham,et al.  CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68. 1 , 1991, Proceedings of the Royal Society of London. Series B: Biological Sciences.

[41]  A. Vitiello,et al.  Analysis of the HLA-restricted influenza-specific cytotoxic T lymphocyte response in transgenic mice carrying a chimeric human-mouse class I major histocompatibility complex , 1991, The Journal of experimental medicine.

[42]  N. Shastri,et al.  Requirement for association of p56 lck with CD4 in antigen-specific signal transduction in T cells , 1991, Cell.

[43]  S. Spencer,et al.  Epitope-specific binding of CD8 regulates activation of T cells and induction of cytotoxicity. , 1990, International immunology.

[44]  P. Parham,et al.  A binding site for the T-cell co-receptor CD8 on the α3 domain of HLA-A2 , 1990, Nature.

[45]  S. D. Gorman,et al.  Inability of CD8α′polypeptides to associate with p56 lck correlates with impaired function in vitro and lack of expression in vivo , 1989, Nature.

[46]  P. Parham,et al.  Polymorphism in the α3 domain of HLA-A molecules affects binding to CD8 , 1989, Nature.

[47]  J. Gabert,et al.  Reconstitution of MHC class I specificity by transfer of the T cell receptor and Lyt-2 genes , 1987, Cell.

[48]  A. Kelso,et al.  Clonal Heterogeneity in the Functional Requirement for Lyt‐2/3 Molecules on Cytolytic T Lymphocytes (CTL): Possible Implications for the Affinity of CTL Antigen Receptors , 1982, Immunological reviews.

[49]  R. Hoffman,et al.  Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[50]  A. Necker,et al.  Human CD8 co-receptor is strictly involved in MHC-peptide tetramer-TCR binding and T cell activation. , 2002, International immunology.

[51]  J. Bell,et al.  BirA enzyme: production and application in the study of membrane receptor-ligand interactions by site-specific biotinylation. , 1999, Analytical biochemistry.

[52]  Mark M. Davis,et al.  LIGAND RECOGNITION BY T CELL RECEPTORS , 1998 .